Carol Keen1,2, Deborah Harrop3, Molly N Hashmi-Greenwood4, David G Kiely5,1, Janelle Yorke6, Karen Sage7. 1. Sheffield Teaching Hospitals NHS Foundation Trust, 7318, Sheffield Pulmonary Vascular Diseases Unit, Sheffield, United Kingdom of Great Britain and Northern Ireland. 2. Sheffield Hallam University College of Health Wellbeing and Life Sciences, 111995, Sheffield, Sheffield, United Kingdom of Great Britain and Northern Ireland; carol.keen@nhs.net. 3. Sheffield Hallam University College of Health Wellbeing and Life Sciences, 111995, Department of Health and Well-being, Sheffield, Sheffield, United Kingdom of Great Britain and Northern Ireland. 4. Sheffield Hallam University Faculty of Health and Wellbeing, 111995, Sheffield, Sheffield, United Kingdom of Great Britain and Northern Ireland. 5. The University of Sheffield, 7315, Department of Infection, Immunity and Cardiovascular Disease, Sheffield, Sheffield, United Kingdom of Great Britain and Northern Ireland. 6. The University of Manchester, 5292, School of Nursing, Midwifery and Social Work, Manchester, Manchester, United Kingdom of Great Britain and Northern Ireland. 7. Manchester Metropolitan University, 5289, Department of Nursing, Manchester, Greater Manchester, United Kingdom of Great Britain and Northern Ireland.
Abstract
RATIONALE: The evidence base for rehabilitation in pulmonary hypertension is expanding but adoption in clinical practice is limited. OBJECTIVES: The World Health Organisation International Classification for Functioning, Disability and Health (ICF) identifies 3 health domains; Body Functions/Structures, Activity and Participation in society. To ensure that the wider impact of rehabilitation in pulmonary hypertension is accurately assessed it is important that study endpoints reflect all three domains. METHODS: A systematic review of the literature was conducted to identify studies of rehabilitation in patients with pulmonary hypertension from 2006 to 2019. RESULTS: Searches across five databases yielded 2564 articles of which 34 met eligibility criteria; 50 different outcome measures (mean=5, min=1, max=9) were identified. When mapped onto the World Health Organisation International Classification for Functioning, Disability and Health, 48% of instances of outcome usage were measures of Body Functions/Structure, 33% were measures of Activity and 18% were measures of Participation. Measures of Participation were not included in seven studies (21%). CONCLUSION: Studies of rehabilitation in pulmonary hypertension have focussed primarily on measures of Body Functions/Structure; the impact in other health domains is not well characterised. Greater inclusion of outcome measures reflecting Activity and Participation in society is needed to allow assessment of the wider impact of rehabilitation in patients with pulmonary hypertension.
RATIONALE: The evidence base for rehabilitation in pulmonary hypertension is expanding but adoption in clinical practice is limited. OBJECTIVES: The World Health Organisation International Classification for Functioning, Disability and Health (ICF) identifies 3 health domains; Body Functions/Structures, Activity and Participation in society. To ensure that the wider impact of rehabilitation in pulmonary hypertension is accurately assessed it is important that study endpoints reflect all three domains. METHODS: A systematic review of the literature was conducted to identify studies of rehabilitation in patients with pulmonary hypertension from 2006 to 2019. RESULTS: Searches across five databases yielded 2564 articles of which 34 met eligibility criteria; 50 different outcome measures (mean=5, min=1, max=9) were identified. When mapped onto the World Health Organisation International Classification for Functioning, Disability and Health, 48% of instances of outcome usage were measures of Body Functions/Structure, 33% were measures of Activity and 18% were measures of Participation. Measures of Participation were not included in seven studies (21%). CONCLUSION: Studies of rehabilitation in pulmonary hypertension have focussed primarily on measures of Body Functions/Structure; the impact in other health domains is not well characterised. Greater inclusion of outcome measures reflecting Activity and Participation in society is needed to allow assessment of the wider impact of rehabilitation in patients with pulmonary hypertension.